Polyphor's Protein Mimetics in $68M Allergan Deal
Polyphor AG secured its first licensing deal with its proprietary Protein Epitope Mimetic (PEM) technology, an alliance in ophthalmology with Allergan Inc., worth up to $68 million. (BioWorld International)